To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Smoking and Lung Cancer
Metropolitan Detroit has the largest population of Middle Eastern/Arab Americans numbering more than 400,000 residents. Given the growing practice of water pipe (WP) smoking, especially among Arab American adolescents, Dr. Rice and colleagues are studying the little known effects of such risk behavior. Compared to cigarette smokers, they expect that WP smoking significantly diminishes lung function and increases health problems among youth. They also expect to see differing patterns, frequency, and intensity of WP use, yet similar or worse health problems as outcomes. The study sites include three public high schools in the Karmanos' catchment area. A detailed water pipe and cigarette smoking "lifetime" history of tobacco use has been obtained from nearly 3000 high school seniors. The 300 students with the longest and most severe water pipe and/or cigarette smoking histories have been asked to participate in saliva cotinine testing (to verify their smoking status) and pulmonary function testing. These students will be compared with nonsmokers matched on key pulmonary function variables (age, gender, height, and ethnicity). The analyses will estimate the effects of smoking status on spirometry outcomes.
For 30 years, Michael Cher, M.D. , urologic oncologist, chief of Urology and member of the Genitourinary Oncology Multidisciplinary Team (MDT), ha...
“If you care about your life and your family members, get the screenings because they are important." Lung cancer is still the leading cause of ca...
The Barbara Ann Karmanos Cancer Institute , along with cancer centers and other organizations nationwide, recognizes November as Pancreatic Cancer...